Stay updated on TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial

Sign up to get notified when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6 in the release information, replacing Revision: v3.6.5. This indicates a site/software update.
    Difference
    0.0%
    Check dated 2026-08-29T19:52:23.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4, indicating a new build of the site. It is a technical update that does not modify study information or how users interact with the page.
    Difference
    0.0%
    Check dated 2026-08-08T20:04:10.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a minor deployment/update. No content changes are indicated by the data provided.
    Difference
    0.0%
    Check dated 2026-07-25T12:50:02.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The site footer revision shows v3.6.3, replacing the previous v3.6.2. This indicates a new software release for the ClinicalTrials.gov interface, likely including fixes or enhancements.
    Difference
    0.0%
    Check dated 2026-07-04T03:51:03.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Expanded the study’s location network to 260 sites by adding several new centers (eg Hospital da Luz in Lisbon; Hubei Cancer Hospital in Wuhan; Tianjin Medical University General Hospital; The Second Peoples Hospital of Neijiang; Haikou Peoples Hospital; Saiseikai Matsusaka Municipal Hospital) across multiple countries. The deletions remove Matsusaka Municipal Hospital and Adana Baskent University, and the total location count changes from 254 to 260.
    Difference
    0.5%
    Check dated 2026-06-27T01:33:56.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate the study is no longer enrolling, and new navigation/help sections were added while a few header labels were adjusted; these changes mainly affect how users access information rather than altering the trial's design or outcomes.
    Difference
    0.1%
    Check dated 2026-06-12T16:35:30.000Z thumbnail image

Stay in the know with updates to TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.